---
title: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic
  bone- and minimal residual disease in multiple myeloma
date: '2024-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39695697/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241219170844&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The combination of stabilization of fracture-prone lesions,
  stimulation of bone healing, and anti-tumor effect suggest clinical testing of sicXer
  and boXer as part of a combined systemic/local treatment strategy in multiple myeloma
  and non-malignant ...'
disable_comments: true
---
CONCLUSIONS: The combination of stabilization of fracture-prone lesions, stimulation of bone healing, and anti-tumor effect suggest clinical testing of sicXer and boXer as part of a combined systemic/local treatment strategy in multiple myeloma and non-malignant ...